Weekly Rounds: ESBL-Producers, Home Infusion Therapy, Lowering SSIs, and More
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 20, 2023.
Here are 5 highlights from Infection Control Today®'s (ICT®’s) wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders to the news that infection preventionists and other health care professionals can use on their jobs.
Preventing Infections in Cancer Patients at Home
Information for health care workers and patients to protect patients from infections.
Routine Change of Surgical Gloves/Instruments Significantly Lowers SSIs
A study clearly shows that surgical site infections (SSIs) can be reduced by changing surgical gloves and instruments before the closing abdominal wound closure.
Moderna: Vaccine Shown Effective Against RSV in Older Adults in Phase III Trial
Moderna announced encouraging news about its RSV mRNA-1345 vaccine and plans to submit for regulatory approval in the first half of 2023.
Considerations for Extended Spectrum Beta-Lactamase (ESBL)-Producers in Nursing Homes
Information for infection preventionists to manage ESBL-producers even while fighting against COVID-19.
Home Infusion Therapy: Study Shows Significant Lack of Formal Infection-Surveillance Training
New study shows home infusion therapy staff have significant barriers to infection-surveillance training, and this could be leading to higher infection rates.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
